Zobrazeno 1 - 10
of 263
pro vyhledávání: '"Vivianne C. G. Tjan‐Heijnen"'
Autor:
Anouk H. Eijkelboom, Linda de Munck, Marie-Jeanne T. F. D. Vrancken Peeters, Mireille J. M. Broeders, Luc J. A. Strobbe, Monique E. M. M. Bos, Marjanka K. Schmidt, Cristina Guerrero Paez, Marjolein L. Smidt, Maud Bessems, Janneke Verloop, Sabine Linn, Marc B. I. Lobbes, Aafke H. Honkoop, Desirée H. J. G. van den Bongard, Pieter J. Westenend, Jelle Wesseling, C. Willemien Menke-van der Houven van Oordt, Vivianne C. G. Tjan-Heijnen, Sabine Siesling, the NABON COVID-19 Consortium and the COVID and Cancer-NL Consortium
Publikováno v:
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-12 (2021)
Abstract Background The onset of the COVID-19 pandemic forced the Dutch national screening program to a halt and increased the burden on health care services, necessitating the introduction of specific breast cancer treatment recommendations from wee
Externí odkaz:
https://doaj.org/article/a57c6e3e85634fe69dad8387aa9a8708
Autor:
Tim C. de Ruijter, Kim M. Smits, Maureen J. Aarts, Irene E. G. van Hellemond, Leander Van Neste, Bart de Vries, Petronella G. M. Peer, Jürgen Veeck, Manon van Engeland, Vivianne C. G. Tjan-Heijnen
Publikováno v:
Diagnostic and Prognostic Research, Vol 3, Iss 1, Pp 1-8 (2019)
Abstract Background The effect of extended adjuvant aromatase inhibition in hormone-positive breast cancer after sequential tamoxifen, aromatase inhibitor treatment of 5 years was recently investigated by the DATA study. This study found no statistic
Externí odkaz:
https://doaj.org/article/f6e07aacda75400586e399d84923b11c
Autor:
Erik W. J. Mollen, Jonathan Ient, Vivianne C. G. Tjan-Heijnen, Liesbeth J. Boersma, Lucio Miele, Marjolein L. Smidt, Marc A. G. G. Vooijs
Publikováno v:
Frontiers in Oncology, Vol 8 (2018)
Breast cancer is the second most common malignancy, worldwide. Treatment decisions are based on tumor stage, histological subtype, and receptor expression and include combinations of surgery, radiotherapy, and systemic treatment. These, together with
Externí odkaz:
https://doaj.org/article/6376bb03046c47fc93f5d8a5609d2987
Autor:
Leonie Voorwerk, Olga I. Isaeva, Hugo M. Horlings, Sara Balduzzi, Maksim Chelushkin, Noor A. M. Bakker, Elisa Champanhet, Hannah Garner, Karolina Sikorska, Claudette E. Loo, Inge Kemper, Ingrid A. M. Mandjes, Michiel de Maaker, Jasper J. L. van Geel, Jorianne Boers, Maaike de Boer, Roberto Salgado, Marloes G. J. van Dongen, Gabe S. Sonke, Karin E. de Visser, Ton N. Schumacher, Christian U. Blank, Lodewyk F. A. Wessels, Agnes Jager, Vivianne C. G. Tjan-Heijnen, Carolien P. Schröder, Sabine C. Linn, Marleen Kok
Publikováno v:
Nature Cancer, 4, 535-549. Springer Nature
Nature Cancer, 4(4), 535-549. Nature Research
Nature Cancer, 4(4), 535-549. Nature Research
Invasive lobular breast cancer (ILC) is the second most common histological breast cancer subtype, but ILC-specific trials are lacking. Translational research revealed an immune-related ILC subset, and in mouse ILC models, synergy between immune chec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::173e4cc0d70da59f93de91b9372cee78
https://doi.org/10.1038/s43018-023-00542-x
https://doi.org/10.1038/s43018-023-00542-x
Autor:
Kristien B. I. M. Keymeulen, Sandra M. E. Geurts, Loes F. S. Kooreman, Lucien E. M. Duijm, Sanne Engelen, Sigrid Vanwetswinkel, Ernest Luiten, Sabine Siesling, Adri C. Voogd, Vivianne C. G. Tjan-Heijnen
Publikováno v:
European Radiology, 33(3), 2209-2217. Springer, Cham
Objectives For patients with ductal carcinoma in situ (DCIS), data about the impact of breast MRI at primary diagnosis on the incidence and characteristics of contralateral breast cancers are scarce. Methods We selected all 8486 women diagnosed with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c041472ab83bb4d239d46706893cbaf
https://doi.org/10.1007/s00330-022-09115-5
https://doi.org/10.1007/s00330-022-09115-5
Autor:
Khava I. E. Ibragimova, Sandra M. E. Geurts, Marissa Meegdes, Frans Erdkamp, Joan B. Heijns, Jolien Tol, Birgit E. P. J. Vriens, Marcus W. Dercksen, Kirsten N. A. Aaldering, Manon J. A. E. Pepels, Linda van de Winkel, Natascha A. J. B. Peters, Nathalie J. A. Teeuwen-Dedroog, Ingeborg J. H. Vriens, Vivianne C. G. Tjan-Heijnen
Publikováno v:
Breast Cancer Research and Treatment, 198(2), 239-251. Springer, Cham
Purpose We assessed the systemic treatment choices and outcomes in patients diagnosed with human epidermal growth factor receptor-2-positive (HER2 +) advanced breast cancer (ABC), for the first four lines of systemic therapy and by hormone receptor (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::091519dce89e341c24a7da6466f819d5
https://doi.org/10.1007/s10549-022-06832-9
https://doi.org/10.1007/s10549-022-06832-9
Autor:
Judith L. Gulikers, Ard J. van Veelen, Elishia M. J. Sinkiewicz, Yvo M. de Beer, Mariëlle Slikkerveer, Leo M. L. Stolk, Vivianne C. G. Tjan‐Heijnen, Lizza E. L. Hendriks, Sander Croes, Robin M. J. M. van Geel
Publikováno v:
Biomedical Chromatography. 37
A liquid chromatography–tandem mass spectrometry method was developed and validated to quantify the small-molecule inhibitors (SMIs) brigatinib, lorlatinib, pralsetinib and selpercatinib, which are used in patients with oncogenic-driven non-small c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::caef5b034fd9d78c2586b3df4ecbcf13
https://cris.maastrichtuniversity.nl/en/publications/af269269-57c0-45bf-8c7f-120860afe266
https://cris.maastrichtuniversity.nl/en/publications/af269269-57c0-45bf-8c7f-120860afe266
Autor:
Anouk K M, Claessens, Jan J V, Busschbach, Bram L T, Ramaekers, Frans L G, Erdkamp, Jeanette M, Bouma, A Elise, van Leeuwen-Stok, Vivianne C G, Tjan-Heijnen, Monique E M M, Bos
Publikováno v:
Acta Oncologica, 61(5), 619-624. Routledge/Taylor & Francis Group
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56b5e077dd118501f9df3bdd08fce02a
https://doi.org/10.1080/0284186x.2022.2033832
https://doi.org/10.1080/0284186x.2022.2033832
Autor:
Marissa Meegdes, Khava I. E. Ibragimova, Dorien J. A. Lobbezoo, Ingeborg J. H. Vriens, Loes F. S. Kooreman, Frans L. G. Erdkamp, M. Wouter Dercksen, Birgit E. P. J. Vriens, Kirsten N. A. Aaldering, Manon J. A. E. Pepels, Linda M. H. van de Winkel, Jolien Tol, Joan B. Heijns, Agnes J. van de Wouw, Natascha A. J. B. Peters, Ananda Hochstenbach-Waelen, Marjolein L. Smidt, Sandra M. E. Geurts, Vivianne C. G. Tjan-Heijnen
Publikováno v:
Breast Cancer Research and Treatment, 192(2), 331-342. Springer, Cham
Purpose The hormone receptor (HR) and human epidermal growth factor receptor 2 (HER2) are the main parameters in guiding systemic treatment choices in breast cancer, but can change during the disease course. This study aims to evaluate the biopsy rat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15a5e909880f3c106d7fac4396b47579
https://doi.org/10.1007/s10549-021-06472-5
https://doi.org/10.1007/s10549-021-06472-5
Autor:
Vivianne C. G. Tjan-Heijnen, L. Janssen, Rudi M. H. Roumen, L.A.D.M. van Osch, Angelique Brands-Appeldoorn, A. J. G. Maaskant-Braat
Publikováno v:
Breast Cancer (Tokyo, Japan)
Breast Cancer, 29(1), 114-120. Springer
Breast Cancer, 29(1), 114-120. Springer
Background The aim of this study was to investigate which factors patients considered to be important for determining the degree of cosmetic satisfaction with regards to perceived body image after previous breast-conserving therapy (BCT). Methods Out
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc6ad1d890386be83311124b25a6ab07
https://doi.org/10.1007/s12282-021-01287-0
https://doi.org/10.1007/s12282-021-01287-0